Cargando…
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
New drugs for multiple myeloma (MM) have dramatically improved patients’ overall survival (OS). Autologous stem cell transplantation (ASCT) remains the mainstay for transplant‐eligible MM patients. To investigate whether the post‐ASCT prognosis of MM patients has been improved by new drugs, we under...
Autores principales: | Shimazu, Yutaka, Mizuno, Shohei, Fuchida, Shin‐ichi, Suzuki, Kazuhito, Tsukada, Nobuhiro, Hanagaishi, Akira, Itagaki, Mitsuhiro, Kataoka, Keisuke, Kako, Shinichi, Sakaida, Emiko, Yoshioka, Satoshi, Iida, Shinsuke, Doki, Noriko, Oyake, Tatsuo, Ichinohe, Tatsuo, Kanda, Yoshinobu, Astuta, Yoshiko, Takamatsu, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645729/ https://www.ncbi.nlm.nih.gov/pubmed/34644446 http://dx.doi.org/10.1111/cas.15163 |
Ejemplares similares
-
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
por: Takamatsu, Hiroyuki, et al.
Publicado: (2023) -
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
por: Murata, Makoto, et al.
Publicado: (2020) -
Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2019) -
Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022) -
Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)